' Misleading ' Results in Colchicine COVID-19 Trials Meta-Analysis ' Misleading ' Results in Colchicine COVID-19 Trials Meta-Analysis

In a meta-analysis of six studies evaluating colchicine as a COVID-19 treatment, the anti-inflammatory drug for acute gout attacks did not appear to improve outcomes for patients.Medscape Medical News
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Source Type: news